{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:07Z","timestamp":1792535947373,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024YFA0916704"],"award-info":[{"award-number":["2024YFA0916704"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173076"],"award-info":[{"award-number":["82173076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573737"],"award-info":[{"award-number":["82573737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172868"],"award-info":[{"award-number":["82172868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470785"],"award-info":[{"award-number":["32470785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRD034"],"award-info":[{"award-number":["SHDC2022CRD034"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Fundamental Research Funds for the Central Universities"},{"name":"Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine Clinic Plus Outstanding Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,11]]},"DOI":"10.1038\/s41388-026-03975-7","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:07:29Z","timestamp":1789578449000},"page":"4703-4714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability"],"prefix":"10.1038","volume":"45","author":[{"given":"Lei","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-2852","authenticated-orcid":false,"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-2087","authenticated-orcid":false,"given":"Haige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"3975_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/jamaoncol.2016.7013","volume":"3","author":"EJ Kouba","year":"2017","unstructured":"Kouba EJ, Cheng L. Understanding the genetic landscape of small cell carcinoma of the urinary bladder and implications for diagnosis, prognosis, and treatment: a review. JAMA Oncol. 2017;3:1570\u20138.","journal-title":"JAMA Oncol"},{"key":"3975_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12022-016-9444-5","volume":"27","author":"E Kouba","year":"2016","unstructured":"Kouba E, Cheng L. Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics. Endocr Pathol. 2016;27:188\u201399.","journal-title":"Endocr Pathol"},{"key":"3975_CR3","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1097\/JS9.0000000000002656","volume":"111","author":"L Liu","year":"2025","unstructured":"Liu L, He LY, Zhang PY, Xiao Y, Wei D, Su RP. Neuroendocrine carcinoma of the bladder: do they have a worse prognosis? A large retrospective cohort study by propensity score matching analysis. Int J Surg. 2025;111:6435\u201340.","journal-title":"Int J Surg"},{"key":"3975_CR4","unstructured":"National Comprehensive Cancer Network. Bladder Cancer (Version 2.2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf. Accessed October 10, 2025."},{"key":"3975_CR5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/cncr.20903","volume":"103","author":"NW Choong","year":"2005","unstructured":"Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer. 2005;103:1172\u20138.","journal-title":"Cancer"},{"key":"3975_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"A Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga A, Chan JM, Yu HA, Pe\u2019er D, Sawyers CL, Sen T, et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat Rev Clin Oncol. 2020;17:360\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"3975_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aah4199","volume":"355","author":"SY Ku","year":"2017","unstructured":"Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science. 2017;355:78\u201383.","journal-title":"Science"},{"key":"3975_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj1415","volume":"383","author":"EE Gardner","year":"2024","unstructured":"Gardner EE, Earlie EM, Li K, Thomas J, Hubisz MJ, Stein BD, et al. Lineage-specific intolerance to oncogenic drivers restricts histological transformation. Science. 2024;383:eadj1415.","journal-title":"Science"},{"key":"3975_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.euo.2019.12.002","volume":"4","author":"J Hoffman-Censits","year":"2021","unstructured":"Hoffman-Censits J, Choi W, Pal S, Trabulsi E, Kelly WK, Hahn NM, et al. Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile. Eur Urol Oncol. 2021;4:297\u2013300.","journal-title":"Eur Urol Oncol"},{"key":"3975_CR10","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-18-3558","volume":"25","author":"J Batista da Costa","year":"2019","unstructured":"Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, et al. Molecular characterization of neuroendocrine-like bladder cancer. Clin Cancer Res. 2019;25:3908\u201320.","journal-title":"Clin Cancer Res"},{"key":"3975_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1158\/1078-0432.CCR-17-3646","volume":"24","author":"MG Oser","year":"2018","unstructured":"Oser MG, Janne PA. Small-cell neuroendocrine tumors: cell state trumps the oncogenic driver. Clin Cancer Res. 2018;24:1775\u20136.","journal-title":"Clin Cancer Res"},{"key":"3975_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1158\/1078-0432.CCR-18-1278","volume":"25","author":"VS Koshkin","year":"2019","unstructured":"Koshkin VS, Garcia JA, Reynolds J, Elson P, Magi-Galluzzi C, McKenney JK, et al. Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target. Clin Cancer Res. 2019;25:210\u201321.","journal-title":"Clin Cancer Res"},{"key":"3975_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1073\/pnas.1915770117","volume":"117","author":"L Wang","year":"2020","unstructured":"Wang L, Smith BA, Balanis NG, Tsai BL, Nguyen K, Cheng MW, et al. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci USA. 2020;117:563\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3975_CR14","doi-asserted-by":"publisher","first-page":"e0134346","DOI":"10.1371\/journal.pone.0134346","volume":"10","author":"CX Pan","year":"2015","unstructured":"Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, et al. Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy. PLoS One. 2015;10:e0134346.","journal-title":"PLoS One"},{"key":"3975_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell. 2018;173:515\u2013528.e517.","journal-title":"Cell"},{"key":"3975_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nrc1235","volume":"3","author":"A Rangarajan","year":"2003","unstructured":"Rangarajan A, Weinberg RA. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2003;3:952\u20139.","journal-title":"Nat Rev Cancer"},{"key":"3975_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13402-023-00822-9","volume":"46","author":"Y Ji","year":"2023","unstructured":"Ji Y, Liu B, Chen L, Li A, Shen K, Su R, et al. Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6\/STAT3 pathway. Cell Oncol (Dordr). 2023;46:1445\u201356.","journal-title":"Cell Oncol (Dordr)"},{"key":"3975_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharm Rev. 2006;58:621\u201381.","journal-title":"Pharm Rev"},{"key":"3975_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43676-3","volume":"14","author":"Y Ji","year":"2023","unstructured":"Ji Y, Zhang W, Shen K, Su R, Liu X, Ma Z, et al. The ELAVL3\/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. Nat Commun. 2023;14:7794.","journal-title":"Nat Commun"},{"key":"3975_CR20","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/1078-0432.CCR-24-1277","volume":"30","author":"J Zang","year":"2024","unstructured":"Zang J, Shahatiaili A, Cai MC, Jin D, Shen P, Qian L, et al. Genomic profiling and immune phenotyping of neuroendocrine bladder cancer. Clin Cancer Res. 2024;30:4920\u201331.","journal-title":"Clin Cancer Res"},{"key":"3975_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.875142","volume":"9","author":"FJ Koll","year":"2022","unstructured":"Koll FJ, Schwarz A, Kollermann J, Banek S, Kluth L, Wittler C, et al. CK5\/6 and GATA3 defined phenotypes of muscle-invasive bladder cancer: impact in adjuvant chemotherapy and molecular subtyping of negative cases. Front Med (Lausanne). 2022;9:875142.","journal-title":"Front Med (Lausanne)"},{"key":"3975_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.eururo.2023.05.023","volume":"85","author":"M Feng","year":"2024","unstructured":"Feng M, Matoso A, Epstein G, Fong M, Park YH, Gabrielson A, et al. Identification of lineage-specific transcriptional factor-defined molecular subtypes in small cell bladder cancer. Eur Urol. 2024;85:523\u20136.","journal-title":"Eur Urol"},{"key":"3975_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1756-8722-7-2","volume":"7","author":"W L\u00fc","year":"2014","unstructured":"L\u00fc W, Wang J. Homoharringtonine and omacetaxine for myeloid hematological malignancies. J Hematol Oncol. 2014;7:2.","journal-title":"J Hematol Oncol"},{"key":"3975_CR24","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-17-2655","volume":"24","author":"MT Chang","year":"2018","unstructured":"Chang MT, Penson A, Desai NB, Socci ND, Shen R, Seshan VE, et al. Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis. Clin Cancer Res. 2018;24:1965\u201373.","journal-title":"Clin Cancer Res"},{"key":"3975_CR25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1078-0432.CCR-13-1982","volume":"20","author":"HL Tan","year":"2014","unstructured":"Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, et al. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res. 2014;20:890\u2013903.","journal-title":"Clin Cancer Res"},{"key":"3975_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen CC, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84\u201388.","journal-title":"Science"},{"key":"3975_CR27","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","volume":"14","author":"M Offin","year":"2019","unstructured":"Offin M, Chan JM, Tenet M, Rizvi HA, Shen R, Riely GJ, et al. Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J Thorac Oncol. 2019;14:1784\u201393.","journal-title":"J Thorac Oncol"},{"key":"3975_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41379-018-0131-6","volume":"32","author":"ER Shamir","year":"2019","unstructured":"Shamir ER, Devine WP, Pekmezci M, Umetsu SE, Krings G, Federman S, et al. Identification of high-risk human papillomavirus and Rb\/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Mod Pathol. 2019;32:290\u2013305.","journal-title":"Mod Pathol"},{"key":"3975_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","volume":"38","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Micinski AM, Kastner DW, Guo B, Wait SJ, Spainhower KB, et al. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell. 2020;38:60\u201378.e12.","journal-title":"Cancer Cell"},{"key":"3975_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1101\/gad.1772909","volume":"23","author":"AM Puzio-Kuter","year":"2009","unstructured":"Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, et al. Inactivation of p53 and PTEN promotes invasive bladder cancer. Genes Dev. 2009;23:675\u201380.","journal-title":"Genes Dev"},{"key":"3975_CR31","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1158\/0008-5472.CAN-21-1254","volume":"81","author":"S Park","year":"2021","unstructured":"Park S, Rong L, Owczarek TB, Bernardo MD, Shoulson RL, Chua CW, et al. Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression. Cancer Res. 2021;81:5161\u201375.","journal-title":"Cancer Res"},{"key":"3975_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jtho.2022.11.019","volume":"18","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu C, Zhang B, Zheng J, Singh PK, Bshara W, et al. PTEN loss expands the histopathologic diversity and lineage plasticity of lung cancers initiated by Rb1\/Trp53 deletion. J Thorac Oncol. 2023;18:324\u201338.","journal-title":"J Thorac Oncol"},{"key":"3975_CR33","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/PAS.0b013e3182159dec","volume":"35","author":"L Cheng","year":"2011","unstructured":"Cheng L, Zhang S, Alexander R, Maclennan GT, Hodges KB, Harrison BT, et al. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol. 2011;35:e34\u201346.","journal-title":"Am J Surg Pathol"},{"key":"3975_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-025-09503-z","volume":"647","author":"AS Ireland","year":"2025","unstructured":"Ireland AS, Xie DA, Hawgood SB, Barbier MW, Zuo LY, Hanna BE, et al. Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer. Nature. 2025;647:257\u201367.","journal-title":"Nature"},{"key":"3975_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ncb2697","volume":"15","author":"ZA Wang","year":"2013","unstructured":"Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol. 2013;15:274\u201383.","journal-title":"Nat Cell Biol"},{"key":"3975_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","volume":"5","author":"R Romero","year":"2024","unstructured":"Romero R, Chu T, Gonzalez Robles TJ, Smith P, Xie Y, Kaur H, et al. The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1. Nat Cancer. 2024;5:1641\u201359.","journal-title":"Nat Cancer"},{"key":"3975_CR37","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.stem.2021.03.022","volume":"28","author":"L Huang","year":"2021","unstructured":"Huang L, Desai R, Conrad DN, Leite NC, Akshinthala D, Lim CM, et al. Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids. Cell Stem Cell. 2021;28:1090\u20131104.e1096.","journal-title":"Cell Stem Cell"},{"key":"3975_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep08477","volume":"5","author":"W Cao","year":"2015","unstructured":"Cao W, Liu Y, Zhang R, Zhang B, Wang T, Zhu X, et al. Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6\/JAK1\/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Sci Rep. 2015;5:8477.","journal-title":"Sci Rep"},{"key":"3975_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijbs.44907","volume":"17","author":"LB Wang","year":"2021","unstructured":"Wang LB, Wang DN, Wu LG, Cao J, Tian JH, Liu R, et al. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p\/AKT\/mTOR signaling pathway. Int J Biol Sci. 2021;17:995\u20131009.","journal-title":"Int J Biol Sci"},{"key":"3975_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109829","volume":"27","author":"C Xi","year":"2024","unstructured":"Xi C, Zhang G, Sun N, Liu M, Ju N, Shen C, et al. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1\/FAK\/PI3K\/AKT signaling pathway. iScience. 2024;27:109829.","journal-title":"iScience"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03975-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:02:57Z","timestamp":1792533777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03975-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":40,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2026,11,11]]}},"alternative-id":["3975"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03975-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}